HC Wainwright & Co. Reiterates Buy on Evolus, Maintains $27 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Douglas Tsao has reiterated a Buy rating for Evolus (NASDAQ:EOLS) and maintained a price target of $27.
October 03, 2024 | 11:18 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HC Wainwright & Co. has reiterated its Buy rating for Evolus, maintaining a price target of $27, indicating confidence in the company's future performance.
The reiteration of a Buy rating and maintenance of a $27 price target by HC Wainwright & Co. suggests a positive outlook for Evolus. This can lead to increased investor confidence and potential upward movement in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100